184 related articles for article (PubMed ID: 8105604)
21. An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML).
Thiele J; Wagner S; Weuste R; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
Eur J Haematol; 1990 Jan; 44(1):63-70. PubMed ID: 2307221
[TBL] [Abstract][Full Text] [Related]
22. Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies.
Thiele J; Wagner S; Bertsch HP; Wienhold S; Fischer R; Dienemann D; Stein H; Zankovich R
Pathol Res Pract; 1990 Oct; 186(5):589-96. PubMed ID: 2287586
[TBL] [Abstract][Full Text] [Related]
23. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura: a morphometric and immunohistochemical study on bone marrow biopsies with special emphasis on precursor cells.
Thiele J; von Ammers E; Wagner S; Degel C; Fisher R
Hematol Pathol; 1991; 5(2):75-82. PubMed ID: 1894584
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
25. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
Marisavljević D; Rolović Z; Mitrović D
Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
[TBL] [Abstract][Full Text] [Related]
26. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
Li X; Pu Q
Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
[TBL] [Abstract][Full Text] [Related]
27. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
[TBL] [Abstract][Full Text] [Related]
28. Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines.
Fox SB; Lorenzen J; Heryet A; Jones M; Gatter KC; Mason DY
Histopathology; 1990 Jul; 17(1):69-74. PubMed ID: 1699866
[TBL] [Abstract][Full Text] [Related]
29. Megakaryocytic ploidy in myelodysplastic syndromes.
Kobayashi Y; Ozawa M; Maruo N; Kondo M
Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
[TBL] [Abstract][Full Text] [Related]
30. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
[TBL] [Abstract][Full Text] [Related]
31. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
32. [Study about proliferation and apoptosis of megakaryocytes in patients with myelodysplastic syndromes].
Li X; Pu Q; Liu YZ; Shi J; Tao Y; Chang CK; Jiang QY; Huang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):40-3. PubMed ID: 12513835
[TBL] [Abstract][Full Text] [Related]
33. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M
Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical detection of normal and abnormal megakaryocytes using monoclonal antibody to glycoprotein IIb-IIIa (TP80): the quantitative assay in normal and in leukaemic patients.
Sato T; Shichishima T; Kimura H; Uchida T; Kariyone S; Ohto H; Maeda H
Scand J Haematol; 1986 May; 36(5):415-23. PubMed ID: 2943015
[TBL] [Abstract][Full Text] [Related]
35. Circulating micromegakaryocytes in myelodysplasia.
Erber WN; Jacobs A; Oscier DG; O'Hea AM; Mason DY
J Clin Pathol; 1987 Nov; 40(11):1349-52. PubMed ID: 3320097
[TBL] [Abstract][Full Text] [Related]
36. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.
Orazi A; Cattoretti G; Soligo D; Luksch R; Lambertenghi-Deliliers G
Leukemia; 1993 Jun; 7(6):838-47. PubMed ID: 7684797
[TBL] [Abstract][Full Text] [Related]
37. A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry.
Jensen IM; Hokland M; Hokland P
Leuk Res; 1993 Oct; 17(10):839-46. PubMed ID: 8412296
[TBL] [Abstract][Full Text] [Related]
38. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
Kitagawa M; Kamiyama R; Kasuga T
Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
[TBL] [Abstract][Full Text] [Related]
39. Megakaryocyte precursors (promegakaryoblasts and megakaryoblasts) in the normal human bone marrow. An immunohistochemical and morphometric study on routinely processed trephine biopsies.
Thiele J; Wagner S; Dienemann D; Wienhold S; Fischer R; Stein H
Anal Quant Cytol Histol; 1990 Aug; 12(4):285-9. PubMed ID: 2206197
[TBL] [Abstract][Full Text] [Related]
40. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
Mori H; Niikura H; Terada H; Fujita K
Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
